Loving your final line EE.
Dovetailed with that, is the reminder that Violin provides just before, that “Scancell is in a stronger position than a year ago”.
Yes, CLN redemption dates draw nearer but clearly imo, there is evidence the Company is now a more attractive proposition to an investor, than just one year ago, even if the SP doesn’t yet reflect that.
Risky? Of course it is. De-risked at least a little over the last year? Think so.
Can’t be certain but I suspect it’s this critter responsible for my malaise this last week. All symptoms match.
https://www.independent.co.uk/news/health/symptoms-of-new-covid-variant-2023-b2428480.html
Don’t want to be a prophet of doom (there is more than enough in the world today already) but I do wonder if this kind of press coverage will once more, become more than a ripple. Will that consequently lift sentiment on stocks with an association (as evidenced previously)? Quite possibly.
Take care out there. HAGW.
My take would be that it’s one patient only and that you can look at what’s being said from multiple angles and interpret, or frankly misinterpret, the message in many different ways.
In other words, looking for a black cat, in a dark room, that isn’t there.
Only from the horse’s mouth will do for me and that horse will be talking soon enough.
After a couple of days of feeling unwell, I tested positive for COVID yesterday and feel like kack today. It prompted me to look at the link below and whilst I’m sceptical about the accuracy of data out there, the direction of travel in the UK appears pretty clear and we haven’t even hit Winter yet. Pretty worrying if you are in the vulnerable bucket, or immunosuppressed.
https://coronavirus.data.gov.uk/
I’ve had all offered 1st Gen vaccinations but surely something more universal and durable is needed to break the cycle of re-infection. Never really believed Covidity would be the answer and was not my principal reason for investing here but maybe there is a very small chance it will lead to something.
Very well done to those who spotted and then took the buying opportunity, or at least interpreted the RNS as much ado about nothing.
Sorry for anyone whose knees were pumping that hard, they spilt coffee all over the dog.
Nice summary and agree on all points Rich.
If you don’t mind, I believe it’s also worth bolting on the managements forward looking statement from the RNS.
“While the economic backdrop is challenging and Ramsdens is not immune to inflationary cost pressures, particularly energy and payroll, the Board remains confident that Ramsdens is in a good position to continue its positive momentum into the new financial year underpinned by the Group's proven and diversified business model, strong brand and clear growth strategy."
So also some confidence from the top, going forward.
Depends on your perspective of course but I would suggest a 50+% rise in the SP over the last month, is hardly a slow drift south. A rise all based on published information (unlike VAL as a for instance).
A couple of pence drift in the short term means nothing to those with real skin in the medium to longer term game, with solid justification for anticipated news updates through Q4.
“More” than £10M Rich :-)
Agree with your earlier post. Very much doubt a 2.5% drop in a week on the price of gold, had much relevance at all.
Crumbs - just for a bit of light relief. Seems I have taken on your crown of pantomime villain over on the other board you used to frequent lol. Hope you get some new here soon.
CW - the reason I haven’t blocked you, is so that I can Rec the posts of others responding to you. Either where their characters & motives have been falsely attacked, or as has happened on several occasions, you have been unable to back up and contextualise posts you have made.
Cleaner - That’s completely untrue. I’ve never advised anyone to block you, or any other poster. Never have, never would.
Your 12:51 post accusing me of that, reminds me of the unwarranted attacks you made on the characters of Berm & Crumbs. Also completely unjustified and something you could not back up.
Embarrassing and yet again, random.
Absolutely Burble. I’m getting caned on a few.
Some posts / posters, make me wonder why they are invested here, in the Bio industry generally, or the Stock Market at all! Perhaps a Building Society would be better for their wellbeing.
Well I guess one question might be what has happened to the 6 month evaluation by a leading biotech company and also the deal with a cell therapy company. Unless of course there is an RNS between now and the meeting. Quite possible imo, particularly given recent quality of communication uplift.
From the 10th July Pipieline Update……..
“ Scancell has developed a novel technology platform for producing monoclonal antibodies that recognise glycans with high specificity and affinity. The platform has generated revenues and the antibodies continue to yield compelling results which have led to a new 6-month evaluation by a leading Biotech company. Additional in-house data has illustrated the potential of our antibodies as chimeric antigen receptor T cell (CART) therapies providing the data for a deal with a cell therapy company. These results along with updates on SCIB1 and Modi-1 will be presented at the AACR-CIMT meeting in Milan in September 2023.”